DIVERSA Technologies

DIVERSA Technologies

Private
Santiago de CompostelaHealthcare & Life Scienceshttps://www.diversatechnologies.com/

Last Round

Seed

Apr 24, 2024

Total Funding Raised

$27,000

Company Overview

DIVERSA Technologies is a biotechnology company that has developed a patented nanotechnology platform based on lipid nanosystems for drug delivery. The company offers its technology through ready-to-use kits, co-development agreements, and contract research services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Advanced Materials, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Non-AI

Keywords

drug delivery platformlipid nanoparticlesLNPintracellular drug deliverynanomedicinedrug formulationnucleic acid deliverycontract R&Ddrug co-developmentdrug delivery systemlipid nanotechnologybiotech licensingresearch kitprotein deliverypeptide delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DIVERSA Technologies Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DIVERSA Technologies Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedApr 24, 2024
AcceleratorSep 11, 2023
AcceleratorJan 17, 2022

DIVERSA Technologies Investors

Notable investors and investment history

InvestorRounds
Unirisco GaliciaSeed
EIT HealthAccelerator
BioIncubaTechAccelerator
Volsunga SLSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 24, 2024

    Led by Unirisco Galicia and Volsunga SL.

  • Sep 11, 2023

    $27K raised from EIT Health.

DIVERSA Technologies Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DIVERSA Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DIVERSA Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersSantiago de Compostela
Year Founded2022
Last FundingApr 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.